Search results
Results from the WOW.Com Content Network
Allergan recalled its Biocell textured breast implants in 2019 due to a link to a rare cancer called BIA-ALCL. The FDA advises women with these implants to have them removed and provides a list of affected models.
The FDA recalled Allergan Biocell textured breast implants and tissue expanders in 2019 due to a link with a rare lymphoma. Learn about the risks, symptoms, and what to do if you have recalled implants.
The FDA has identified a link between Allergan BIOCELL textured breast implants and a rare type of cancer called BIA-ALCL. The agency has asked Allergan to voluntarily recall these products...
Allergan announces a global voluntary recall of BIOCELL® textured breast implants and tissue expanders due to the uncommon risk of breast implant-associated anaplastic large cell...
Allergan voluntarily recalled their BIOCELL textured breast implants in July 2019 due to increased risk of BIA-ALCL, a rare but serious condition. Learn about the recalled implant styles, the symptoms and treatment of BIA-ALCL, and the replacement warranty offered by Allergan.
The FDA found that Allergan failed to comply with post-approval study requirements for two models of breast implants that were recalled due to increased risk of ALCL. The agency also warned Ideal...
The action was initiated following notification by the U.S. FDA of their recently updated, global safety information concerning the higher incidence of anaplastic large cell lymphoma...